Abbott India elevates Anushree Kunhambu as Associate Director - New Product Introduction and Therapy Area Strategy

Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio

Our TB elimination strategy is based on ‘whole of the society’ and ‘whole of the government’ approach: JP Nadda

Nadda noted that TB treatment coverage in India has increased from 59% to 85%

Bayer’s pharma growth strategy progressing well as pipeline advances

Regulatory filings underway for a third indication for darolutamide in prostate cancer, for finerenone in a common form of heart failure, and acoramidis in transthyretin amyloid

Lonza outlines strategy, new organizational structure and guidance

The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities

Avallano appoints Michael A. Ibara as Chief Strategy Officer

Ibara will drive AI-powered clinical research innovation

Moderna Chief Commercial Officer steps down, President to look over pipeline strategy

Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025

Apollo Hospitals appoints Dr. Madhu Sasidhar as Chief Strategy Officer

SSI Strategy to acquires NDA Group partner to form global life sciences consultancy

Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base

Healthium Medtech appoints Dr. Vivek S. Iyer as GM for Professional Education & Market Growth Strategy

Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson

Rystiggo needs marketing strategy to fully compete in myasthenia gravis space, says GlobalData

Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024